Can you interpret the bone density results for a 71‑year‑old patient, including lumbar spine, left femoral‑neck, and left total‑hip T‑scores and the FRAX 10‑year fracture risk estimates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bone Density Interpretation for 71-Year-Old Patient

Your bone density results are normal by WHO criteria, and you do not meet the threshold for osteoporosis medication at this time. However, the 4.7% decrease in your left total hip BMD warrants close monitoring with repeat DEXA scanning in 1-2 years 1.

Understanding Your Results

T-Score Classification

All three measured sites fall within the normal range:

  • Lumbar spine (L1-L4): T-score 0.0 (normal)
  • Left femoral neck: T-score -0.6 (normal)
  • Left total hip: T-score -0.3 (normal)

According to WHO criteria, osteoporosis is diagnosed when T-scores are ≤-2.5, and low bone mass (osteopenia) is defined as T-scores between -1.0 and -2.5 1, 2. Your scores are all above -1.0, placing you in the normal category.

Z-Score Interpretation

Your Z-scores (comparing you to age-matched peers) are all positive (+1.1 to +1.5), meaning your bone density is actually better than average for a 71-year-old woman 3.

FRAX Fracture Risk Assessment

Your 10-year fracture probabilities are:

  • Major osteoporotic fracture: 8.3%
  • Hip fracture: 1.2%

These values are below the treatment thresholds. The American Association of Clinical Endocrinologists recommends pharmacologic therapy when FRAX shows ≥20% risk for major osteoporotic fracture OR ≥3% risk for hip fracture in patients with T-scores between -1.0 and -2.5 1, 2. Since your T-scores are above -1.0 AND your FRAX scores are below these thresholds, medication is not indicated.

The Concerning Finding: Hip BMD Decline

The 4.7% decrease in your left total hip BMD from the previous scan is significant and requires attention. While you don't currently need medication, this rate of bone loss suggests you should be evaluated for:

Secondary Causes of Bone Loss

  • Vitamin D deficiency
  • Calcium malabsorption
  • Thyroid disorders (hyperthyroidism)
  • Hyperparathyroidism
  • Medications causing bone loss (glucocorticoids, proton pump inhibitors, certain diabetes medications)
  • Excessive alcohol consumption
  • Smoking 1

Recommended Actions

Non-Pharmacologic Interventions (Essential)

Calcium and Vitamin D supplementation:

  • Calcium: 1,000-1,200 mg daily
  • Vitamin D: 800-1,000 IU daily 1, 4, 1

Exercise program (strongly recommended):

  • Weight-bearing exercises (walking, stair climbing, dancing)
  • Resistance/strength training
  • Balance exercises (Tai Chi)
  • This combination reduces fracture risk by preventing falls and modestly improving bone density 1, 2

Lifestyle modifications:

  • Stop smoking if applicable 1, 2
  • Limit alcohol to ≤2 units per day 1

Fall prevention strategies:

  • Home safety assessment
  • Consider physical therapy referral for balance training and gait stability 1, 2

Follow-Up Monitoring

Repeat DEXA scan in 1-2 years at the same facility for accurate comparison 1. Given the significant hip BMD decline, annual monitoring may be more appropriate to detect continued bone loss early.

If your next DEXA shows:

  • Further decline in BMD, OR
  • T-score dropping to ≤-2.5, OR
  • FRAX scores rising to ≥20% for major fracture or ≥3% for hip fracture

Then pharmacologic therapy with bisphosphonates (alendronate, risedronate, zoledronate) or denosumab would be strongly recommended 1, 5, 2.

Important Caveats

Most fragility fractures occur in patients with T-scores above -2.5 6. If you experience any low-trauma fracture (hip, spine, wrist, humerus) in the future, this would change your risk category entirely and warrant immediate treatment regardless of BMD values 1, 2, 6.

The recent USPSTF screening trials showed that even in women with FRAX scores similar to yours, screening and appropriate intervention reduced hip fractures by 17% and major osteoporotic fractures by 6% over 3.7-5 years 5. This underscores the importance of your continued monitoring and adherence to non-pharmacologic interventions.

Related Questions

Interpret the DEXA and FRAX results for a 62‑year‑old female (lumbar spine T‑score +1.6, left femoral‑neck T‑score –0.6, left total‑hip T‑score +0.5, 10‑year major osteoporotic fracture risk 6%, hip fracture risk 0.2%) and advise on management.
Can you explain in layperson terms my ten-year major osteoporotic fracture risk (11%) and hip fracture risk (1.5%) given osteopenia of the left proximal femur, normal lumbar spine, and decreasing bone mineral density?
What does a FRAX hip fracture risk of 13% over ten years indicate and how should it be managed?
Should a patient be classified as very high fracture risk based solely on a T-score less than –3 at the distal radius?
Can you explain the bone density results (ten-year major osteoporotic fracture risk 7.3%, hip fracture risk 0.7%, WHO classification osteopenia, lumbar spine BMD increase 2.8%, left hip BMD increase 1.2%) in layperson terms and provide a brief summary note for the patient?
What non‑surgical treatments can be used to shrink uterine fibroids?
A patient has a cystatin C of 1.23 mg/L corresponding to an estimated glomerular filtration rate of approximately 60 mL/min/1.73 m²; what are the next steps in management?
How should a white blood cell count of 2.7 × 10⁹/L and an absolute neutrophil count of 1,118 cells/µL be interpreted and managed?
Does elevated cortisol increase the risk of herpes zoster (shingles) reactivation?
What is the recommended dosing schedule for senna (sennosides) in adults, including maximum daily dose and adjustments for elderly or patients with renal/hepatic impairment?
In a 63-year-old man with normal sinus rhythm, occasional brief palpitations, exertional dyspnea with pleuritic chest discomfort, mild renal impairment (eGFR 55 mL/min/1.73 m², creatinine 1.33 mg/dL), and blood pressure only mildly controlled on losartan 100 mg, what are the appropriate diagnostic and therapeutic steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.